Product Detail

Current Location: Home> Cytokines & Growth Factors>VEGFs>Y04701 Recombinant Human VEGF165
Y04701 Recombinant Human VEGF165

Synonym: VEGF165

Species: Human

Protein Accession: Y04701

Purity: Greater than 95%

Endotoxin Level: Less than 1 EU/µg

Biological Activity: The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells (HUVEC) is less than 1.0 ng/ml.

Expression System: CHO cells

Fusion Tag: None

Predicted Molecular Mass: Approximately 38 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution in PBS

Reconstitution: It is recommended to reconstitute the lyophilized VEGF165 in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.

Storage & Stability: Lyophilized VEGF165 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution, VEGF165 should be stored at 4°C between 2-7 days and for future use below -18°C.

FAQ

What is Y04701 Recombinant Human VEGF165, and how does it benefit animal feed?

Y04701 Recombinant Human VEGF165 is a bioengineered protein that mimics the Vascular Endothelial Growth Factor (VEGF) found naturally in humans. In the context of animal feed, this recombinant protein can have multiple benefits. VEGF165 plays a crucial role in angiogenesis, the formation of new blood vessels from pre-existing ones. This process is vital for ensuring adequate oxygen and nutrient supply to tissues. When incorporated into animal feed, VEGF165 can enhance growth performance by improving blood circulation and nutrient absorption in animals. Improved angiogenesis can lead to better muscle development, higher rates of weight gain, and overall healthier livestock. Enhanced blood flow can also aid in waste removal and better immune responses, reducing disease susceptibility.

How does Y04701 Recombinant Human VEGF165 improve the health of livestock?

The administration of Y04701 Recombinant Human VEGF165 in animal feed can significantly improve livestock health through several mechanisms. First, by promoting angiogenesis, VEGF165 ensures that tissues receive adequate blood supply, which is essential for the delivery of nutrients and oxygen and the removal of waste products. This can lead to improved cellular function and overall better health. Additionally, better vascularization can support more robust immune responses by facilitating the transport of immune cells to sites of infections or injuries. Furthermore, enhanced blood flow can help maintain optimal body temperature and improve metabolism, contributing to well-balanced physiological functions. All these factors collectively lead to healthier, more resilient livestock, capable of better growth and higher production yields.

Can Y04701 Recombinant Human VEGF165 be used safely across different species of livestock?

Yes, Y04701 Recombinant Human VEGF165 can be safely used across different species of livestock, including poultry, swine, cattle, and sheep. The protein is designed to be species-agnostic in its angiogenic effects, making it a versatile additive for various types of animal feed. However, it's essential to adhere to recommended dosage guidelines specific to each species to ensure maximum efficacy and safety. Extensive research has shown that VEGF165 has a low toxicity profile, minimizing the risk of adverse effects when used appropriately. Moreover, ongoing studies continue to evaluate its safety across multiple species, further confirming its broad applicability. Veterinarians and animal nutritionists should be consulted to tailor the optimal dosage and administration strategy for different types of livestock, ensuring that the benefits are maximized while mitigating any potential risks.

What are the potential side effects of using Y04701 Recombinant Human VEGF165 in animal feed?

While Y04701 Recombinant Human VEGF165 has a low toxicity profile and is generally safe for use in animal feed, there are some potential side effects to consider. Overdosage or improper administration could lead to excessive angiogenesis, which might cause abnormal tissue growth and complications such as edema or unintended vascular issues. In rare cases, there could be hypersensitivity or allergic reactions, manifesting as skin irritations or gastrointestinal disturbances. It’s crucial to follow dosage recommendations strictly and consult with a veterinarian or animal nutritionist for personalized advice tailored to specific livestock needs. Regular monitoring for any signs of adverse effects during the initial phases of administration is also advisable. This proactive approach ensures that any potential issues can be identified and addressed promptly, thereby safeguarding animal health and optimizing the benefits of Y04701 Recombinant Human VEGF165.

How should Y04701 Recombinant Human VEGF165 be administered in animal feed for optimal results?

For optimal results, Y04701 Recombinant Human VEGF165 should be precisely dosed and uniformly mixed into the animal feed. The concentration generally depends on the specific type of livestock, their age, weight, and health status. It's best to use automated feed mixing equipment to ensure even distribution of the recombinant protein throughout the feed, which guarantees that each animal receives a consistent and effective dose. Liquid formulations can be sprayed onto feed, while powdered forms can be blended directly. Periodic reassessment is crucial to adjust the dosage based on growth performance, health status, and specific farm conditions. It's recommended to start with a lower dose and gradually increase it while monitoring the animals for any changes in behavior, growth rates, and overall health. Consulting with a veterinarian or an animal nutritionist can provide additional guidance tailored to your specific livestock needs, ensuring that Y04701 Recombinant Human VEGF165 delivers maximum benefits in animal feed.

Jiangsu East-Mab Biomedical Technology Co.,Ltd

contact us

Factory address:
Life and Health Industrial Park, Rudong County, Nantong City, Jiangsu Province

Contact: Fred Wang
Tel: 0086-25-52397805
Phone/WhatsApp: 0086-18005193850

mobile
Jiangsu East-Mab Biomedical Technology Co.,Ltd

Copyright(C)2023,Jiangsu East-Mab Biomedical Technology Co.,Ltd All Rights Reserved.

Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.